Nanologica AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0005454873
SEK
0.46
0 (-0.65%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Nanologica AB
IRLAB Therapeutics AB
Medivir AB
Orexo AB
InDex Pharmaceuticals Holding AB
Cereno Scientific AB
SynAct Pharma AB
Initiator Pharma A/S
Diamyd Medical AB
Guard Therapeutics International AB
Kancera AB

Why is Nanologica AB ?

1
With a growth in Net Sales of 312.22%, the company declared Outstanding results in Mar 26
  • OPERATING CASH FLOW(Y) Highest at SEK -26.85 MM
  • ROCE(HY) Highest at 31.15%
  • RAW MATERIAL COST(Y) Fallen by -57.35% (YoY)
2
With ROE of -221.74%, it has a attractive valuation with a 7.26 Price to Book Value
  • Over the past year, while the stock has generated a return of -68.54%, its profits have risen by 23.5%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Nanologica AB should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Nanologica AB for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Nanologica AB
-68.54%
-0.68
143.33%
OMX Stockholm 30
27.7%
1.79
15.50%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
12.08%
EBIT Growth (5y)
-28.78%
EBIT to Interest (avg)
-10.37
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.34
Sales to Capital Employed (avg)
-0.01
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
7.26
EV to EBIT
-4.59
EV to EBITDA
-6.10
EV to Capital Employed
3.06
EV to Sales
9.97
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-66.61%
ROE (Latest)
-221.74%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Bearish
Bearish
OBV
No Trend
Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

38What is working for the Company
OPERATING CASH FLOW(Y)

Highest at SEK -26.85 MM

ROCE(HY)

Highest at 31.15%

RAW MATERIAL COST(Y)

Fallen by -57.35% (YoY

NET SALES(Q)

Highest at SEK 21.46 MM

OPERATING PROFIT(Q)

Highest at SEK -4.29 MM

OPERATING PROFIT MARGIN(Q)

Highest at -20.01 %

PRE-TAX PROFIT(Q)

Highest at SEK 65.19 MM

NET PROFIT(Q)

Highest at SEK 65.19 MM

EPS(Q)

Highest at SEK 0.72

-7What is not working for the Company
INVENTORY TURNOVER RATIO(HY)

Lowest at 2.23 times

INTEREST(Q)

At SEK 1.46 MM has Grown at 36.61%

DEBT-EQUITY RATIO (HY)

Highest at 81.86 %

Here's what is working for Nanologica AB

Net Sales
At SEK 21.46 MM has Grown at 306.09%
over average net sales of the previous four periods of SEK 5.28 MM
MOJO Watch
Near term sales trend is extremely positive

Net Sales (SEK MM)

Pre-Tax Profit
At SEK 65.19 MM has Grown at 619.27%
over average net sales of the previous four periods of SEK -12.55 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (SEK MM)

Net Profit
At SEK 65.19 MM has Grown at 619.27%
over average net sales of the previous four periods of SEK -12.55 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (SEK MM)

Operating Cash Flow
Highest at SEK -26.85 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

Net Sales
Highest at SEK 21.46 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (SEK MM)

Operating Profit
Highest at SEK -4.29 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (SEK MM)

Operating Profit Margin
Highest at -20.01 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at SEK 65.19 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (SEK MM)

Net Profit
Highest at SEK 65.19 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (SEK MM)

EPS
Highest at SEK 0.72
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (SEK)

Raw Material Cost
Fallen by -57.35% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at SEK 5.6 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (SEK MM)

Depreciation
At SEK 5.6 MM has Grown at 124.16%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (SEK MM)

Here's what is not working for Nanologica AB

Interest
At SEK 1.46 MM has Grown at 36.61%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Inventory Turnover Ratio
Lowest at 2.23 times and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debt-Equity Ratio
Highest at 81.86 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio